BioGaia AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 315.22 million compared to SEK 288.09 million a year ago. Net income was SEK 80.55 million compared to SEK 78.55 million a year ago. Basic earnings per share from continuing operations was SEK 0.8 compared to SEK 0.78 a year ago. Diluted earnings per share from continuing operations was SEK 0.8 compared to SEK 0.78 a year ago.
For the six months, sales was SEK 681.04 million compared to SEK 571.94 million a year ago. Net income was SEK 196.49 million compared to SEK 154.84 million a year ago. Basic earnings per share from continuing operations was SEK 1.95 compared to SEK 1.53 a year ago. Diluted earnings per share from continuing operations was SEK 1.95 compared to SEK 1.53 a year ago.